首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 62 毫秒
1.
复方花刺参制剂抗凝血机制的实验研究   总被引:5,自引:2,他引:5  
本研究旨在探讨复方花刺参制剂(Stichopus variegatus Compoud ST复合剂)对大鼠血浆TXB2、6-keto-PGF1a、PGE2、Fg及其对大鼠血小板聚集的影响。实验采用酶联免疫吸附法(ELISA法)测定各组大鼠血浆中TXB2、6-Ke-PGF1a、PGE2的水平;另外,采用免疫比浊法测定两组大鼠血浆中纤维蛋白原(Fg)的含量,并同时观察各组大鼠3min,10min内的血  相似文献   

2.
Inhibitory effects of copper-aspirin complex on platelet aggregation   总被引:3,自引:1,他引:2  
目的:研究阿司匹林铜(CuAsp)对血小板聚集性的影响及其机制.方法:用Born氏法测定CuAsp对兔血小板聚集性的影响.用荧光光度法和放射免疫法观察CuAsp对兔血小板5羟色胺的释放和TXB2的产生及血浆中TXB2和6ketoPGF1α水平的影响.结果:CuAsp体外呈浓度依赖性抑制花生四烯酸(AA)诱导的血小板聚集和5羟色胺的释放(IC50分别为17和19μmol·L-1,95%可信限为9-33和10-30μmol·L-1),且抑制TXB2的产生(P<005).CuAsp10mg·kg-1灌胃选择性抑制AA诱导聚集.降低血浆TXB2,同时升高6ketoPGF1α的水平(P<005).结论:CuAsp体内外均有比Asp更强的抗血小板聚集作用.  相似文献   

3.
10例慢性支气管炎缓解期患者和10例正常人的肺泡巨噬细胞(AM),加用LPS体外培养。结果显示随着培养基中LPS剂量增加,两组AM合成分泌的6-酮-前列腺素F1α(6-keto-PGF1α)和血栓素B2(TXB2)含量均逐渐增加。两组间存在显著差异性。表明慢性支气管炎缓解期患者AM更易活化释放这些炎性介质。对慢性支气管炎发生发展有重要影响  相似文献   

4.
目的: 研究小剂量阿斯匹林(ASA) 对冠心病患者血小板释放反应的影响及其机制。方法: 采用放免法(RIA) 对40 例稳定期冠心病志愿者口服单剂40 mg (20 例) 与300 mg (20 例) ASA 前后血浆β TG. 6 酮 PGF1α及TXB2 进行定量分析。结果: (1) 口服单剂40 mg ASA 24 h 血浆β TG 显著减少( P< 0-05) , 血浆TXB212 h 与24 h 均非常显著下降( P< 0-01) , 而血浆6 酮 PGF1α几乎不变( P> 0-05) ; (2) 口服单剂300 mg ASA 除了6 酮 PGF1α显著降低( P< 0-05) 外, 血浆β TG 及TXB2 变化态势同40 mg 组。结论: 口服单剂40 mg 与300 mgASA 均能显著阻抑血小板释放反应, 此作用似与ASA 降低机体TXA2 水平有关;300 mgASA 可使体内PGI2 含量减少, 无法改善冠心病者PGI2/TXA2 平衡。  相似文献   

5.
目的:研究阿司匹林铜(CuAsp)对血小板聚集性的影响及其机制,方法;用Born氏法测定CuAsp对兔血小板聚集性的影响,用荧光光度法和放射免疫法观察CuAsp对兔血小板5-羟色胺的释放和TXB2的产生及血浆中TXB2和6-keto-PGF1α水平的影响,结果:CuAsp体外呈浓度依赖性抑制花生四烯酸(AA)诱导的血小板聚集和5-羟色胺的释放(IC50分别为17和19μmol.L^-1,95%可信  相似文献   

6.
目的 研究小剂量阿斯匹林(ASA)对冠心病患者血小板释放反应的影响及其机制。方法采用放免法(RIA)对40例稳定期冠心病志愿者口服单剂40mg(20例)与300mg(20例)ASA前后血浆β-TG,6-酮-PGF1α及TXB2进行定量分析。结果:(1)口服单剂40mgASA 24h血浆β-TG显著减少(P〈0.05),血浆TXB2 12h与24h均非常显著下降(P〈0.01),而血浆6-酮-PGF  相似文献   

7.
缩宫汤治疗子宫肌瘤月经异常(气虚血瘀型)初步研究   总被引:5,自引:0,他引:5  
为了研究缩宫汤对子宫肌瘤月经异常(气虚血瘀型)患者的作用及其机制。观察40例患者治疗前后经量、经期的变化,并测定血浆TXB2、6-keTo-PGF1a浓度。结果缩宫汤止血有效率为82.5%,除6-keTo-PGF1a外,TXB2、T/K均显著高于正常对照组(P〈0.01)。缩宫汤治疗后,除6-keTo-PGF1a皆有显著降低(P〈0.01),T/K趋于正常。提示调节血栓素A2(TXA2)、前列环素  相似文献   

8.
阿莫西林及其胶囊的氧瓶燃烧电位滴定   总被引:2,自引:0,他引:2  
阿莫西林及其胶囊的氧瓶燃烧电位滴定韩学静,杨立新,唐之秀(河北省药品检验所,石家庄050011;石家庄市新华制药厂,石家庄050091)POTENTIOMETRICTITRATIONOFAMOXICILLINANDITSCAPSULESBYOXYGE...  相似文献   

9.
目的 研究绞股蓝总皂苷( Gyp) 对血管平滑肌细胞增殖的调节与内皮细胞c sis 基因表达和一氧化氮( N O) 合成/ 释放的关系。方法 采用原位杂交法检测内皮细胞c sism R N A 表达,用 Griess 法测定内皮细胞 N O 释放量,用 M T T快速比色法检测平滑肌细胞( S M C) 增殖。结果 内毒素( L P S)16 mg· L- 1 促进牛主动脉内皮细胞c sis 基因表达,明显降低内皮细胞培养液中一氧化氮含量,刺激 S M C 增殖;黄嘌呤- 黄嘌呤氧化酶( X X O) 系统产生的氧自由基( O F R) 具有与 L P S 相似的作用。绞股蓝总皂苷对 L P S诱导的内皮细胞c sis 基因表达具有明显抑制作用,并能对抗 O F R 诱导的 E C 损伤,保护内皮细胞释放 N O 的能力,抑制 L P S 和 O F R通过 E C 介导的 S M C 增殖。 Gyp 的效应可被 N O 合成酶抑制剂硝基 左旋精氨酸部分取消。结论 绞股蓝总皂苷通过抑制内皮细胞c sis 基因表达,促进内皮细胞合成( 释放) N O抑制平滑肌细胞增殖  相似文献   

10.
本文研究一氧化氮减少对孕鼠血浆内皮素(ET)、血栓素B2(TXB2)、6-酮-前列腺素F1α(6-keto-PGF1α)等血管活性因子的影响。结果显示妊娠大鼠血浆ET、TXB2、6-keto-PGF1α均升高,TXB2/6-keto-PGF1α比值降低,未妊娠大鼠血浆ET升高,6-keto-PGF1α降低,TXB2无显著变化,TXB2/6-keto-PGF1α比值升高。说明孕鼠体内一氧化氮减少时,ET及TXB2上升,血管收缩,而作为代偿和保护机制,6-keto-PGF1α升高,TXB2比值降低。未妊娠大鼠无此代偿效应。  相似文献   

11.
目的:建立同时测定地龙中4个黄曲霉毒素含量的高效液相色谱串联质谱法。方法:样品经甲醇-水(80∶20,v/v)提取,通过免疫亲和柱净化后,采用高效液相色谱串联质谱法测定其中4个黄曲霉毒素的含量,以多反应监测(MRM)方式分别监测离子对m/z 313→241(黄曲霉毒素B1,CE 50 eV),m/z 315→259(黄曲霉毒素B2,CE 43 eV),m/z 329→243(黄曲霉毒素G1,CE 38 eV)和m/z 331→245(黄曲霉毒素G2,CE 40 eV)。结果:黄曲霉毒素B1、B2、G1、G2的检测限分别为0.03,0.02,0.03,0.02μg.kg-1,回收率在88.0%~100.3%范围内,RSD均低于6.1%。结论:该方法快速、灵敏,结果准确,适用于地龙中4个黄曲霉毒素的同时检测。  相似文献   

12.
郭巧技  高咏莉  王淑红 《中国药师》2012,(12):1696-1698
目的:建立了HPLC法测定150种中药材中的黄曲霉毒素G2、G1、B2、B1含量。方法:样品经70%甲醇提取、免疫亲和色谱柱净化后,用HPLC-柱后衍生-荧光检测器测定结果:黄曲霉毒素G1、B2在0.15~6.00 ng·ml-1范围内,黄曲霉毒素C1、B1在0.5~20.00 ng·ml-1范围内线性关系良好回收率为85.6%~92.0%结论:本法操作简便,结果准确、重复性好,可用于中药材中黄曲霉毒素G2、G1、B2、B1的测定  相似文献   

13.
Enniatins (ENs) are ionophoric, phytotoxic, antihelminthic, and antibiotic compounds of hexadepsipeptidic structure produced by several strains of Fusarium spp. The cytotoxicity effect of the ENs A, A1, A2, B, B1, B4 and J3 was compared on three tumor cell lines, the human epithelial colorectal adenocarcinoma (Caco-2), the human colon carcinoma (HT-29), and the human liver carcinoma (Hep-G2). The endpoint evaluated was the mitochondrial integrity by using the MTT assays, after 24 and 48 h of incubation. The IC50 value for EN A2 on Caco-2 cells, after 24 h exposure, was 18.7 ± 4.5 μM and decrease to 2.6 ± 0.7 μM at 48 h of incubation. However, ENs A, A1, B1 and B4 exert pronounced cytotoxic effects in all the cell lines tested by the MTT assay after 24 and 48 h of incubation. The EN A1 demonstrated to be the most cytotoxic ENs tested. Moreover, no statistical differences were found between the IC50 values obtained for EN A1 on Caco-2, HT-29 and Hep-G2, with IC50 values ranging from 9.1 ± 2.2 μM to 12.3 ± 4.3 μM at 24 h and decreasing in a range variable from 1.4 ± 0.7 μM to 2.7 ± 0.8 μM at 48 h. On the other hand, EN A, B1 and B4 showed lower cytotoxicity, but in a similar range as the IC50 values reported on HT-29 (IC50 values (24 h): 16.8 ± 4.3-26.2 ± 6.7 μM), Caco-2 (IC50 values (24 h): 19.5 ± 4.1 μM) and Hep-G2 (IC50 values (24 h): 23.4 ± 5.6-26.2 ± 7.6 μM) cells. Cytotoxic effect with a 48 h of incubation revealed also a significant toxicity of ENs A (IC50 values ranged from 8.2 ± 1.8 to 11.4 ± 4.6 μM), B1 (IC50 values variables from 3.7 ± 0.7 to 11.5 ± 5.3 μM) and B4 (IC50 of 4.5 ± 2.9-15.0 ± 4.0 μM). In summary, this study demonstrated that ENs can exert toxic activity at low micromolar concentrations in mammalian cells.  相似文献   

14.
15.
摘要:目的 研究海藻酸盐敷料的止血性能,并初步探究其生物相容性。方法 采用凝血指数试验测定体外凝血性能。采用新西兰兔耳和背部创伤止血试验测定止血性能。采用溶血试验和细胞毒性试验进行初步安全性评价。结果海藻酸盐敷料、明胶海绵的凝血指数BCI分别为33.1±4.9、72.0±3.3,海藻酸盐敷料凝血效果优于明胶海绵。在背部创伤出血模型中,海藻酸盐敷料、明胶海绵、纱布的平均止血时间为(55.3±5.1)s、(80.2±7.4)s、(101±14.7)s,Hb光度吸收值分别为1.5±0.7、2.5±0.5、3.8±0.7。与明胶海绵比较,海藻酸盐敷料的平均止血时间缩短了31.05%,Hb光度吸收值降低了40.00%;与纱布比较,海藻酸盐敷料的平均止血时间缩短了45.25%,Hb光度吸收值降低了60.53%。在兔耳动脉止血实验中,海藻酸盐敷料、明胶海绵、纱布的出血量分别为(2.4±0.2)g、(3.0±0.2)g、(3.9±0.2)g,止血时间分别为(226.3±6.5)s、(332.3±14.2)s、(466.5±19.1)s。与明胶海绵组比较,海藻酸盐敷料的出血量降低了20.00%,止血时间分别为缩短了31.90%;与纱布比较,海藻酸盐敷料的出血量降低了38.46%,出血时间缩短了51.49%。海藻酸盐敷料的溶血率低于5%。细胞毒性实验中各浓度的海藻酸盐敷料浸提液为0级或1级,提示其对细胞无明显毒性。结论 海藻酸盐敷料具有良好的止血效果,溶血率符合国标要求,且对皮肤成纤维细胞无细胞毒性。  相似文献   

16.
The vasodepressor actions of the cyclic endoperoxides PGG2 and PGH2 were compared with those of their products PGD2 and PGE2 using anaesthetised normotensive and genetically hypertensive rats. Given into the aortic arch of normotensives PGE2 was approximately 6 times more potent than PGH2 and 11 times more potent than PGG2 and PGD2. Hypertensive animals were 1.5–10 times more sensitive than normotensives to the depressor effects of PGG2 and PGH2, but their sensitivity to either PGD2 or PGE2 was similar. Thus in hypertensives the endoperoxides may be converted more readily to PGE2 and other products.In both types of rat PGG2 and PGH2 given intravenously were as active or more active than after intra-arterial administration. Low but not high intravenous doses of PGE2 were less effective than intra-arterial. Therefore PGG2 and PGH2 may be converted more readily to more active products during passage through the lungs but whereas small doses of PGE2 are almost completely eliminated large doses may saturate pulmonary removal mechanisms.  相似文献   

17.
目的建立高效液相色谱–光化学衍生–荧光检测法测定沉香药材中黄曲霉毒素B1、B2、G1、G2。方法采用高效液相色谱法,通过免疫亲和柱提取和净化,荧光检测器检测。Agilent Zorbax Ecilpse Plus C18色谱柱(250 mm×4.6 mm,5μm);流动相:甲醇–水(45∶55);体积流量:0.8 m L/min;柱温:30℃;进样盘温度:4℃;荧光激发波长为360 nm,发射波长为450 nm。结果黄曲霉毒素B1、B2、G1、G2分别在9.3~74.4、3.0~24.0、9.3~74.4、3.5~28.0 pg线性关系良好,r均大于0.998 0;检测限分别为1.86、0.60、1.86、0.70 pg,定量限分别为7.44、2.40、7.44、2.80 pg。平均回收率分别为78%、92%、82%、99%,RSD值分别为4.4%、3.0%、4.3%、2.8%。结论所建立的方法结果准确、重复性、稳定性均良好,可用于沉香药材中黄曲霉毒素的质量控制。  相似文献   

18.
A range of antipsychotic drugs, both “typical” and “atypical”, was administered to rats over a time course and at several different dosages. The mRNA levels of dopamine D1 , D2 and D3 receptor were measured in either whole brain or dissected brain regions. D3 receptor mRNA was up-regulated in whole brain by clozapine (10 and 30 but not 3 mg/kg/day), sulphide (50 and 100 but not 20 mg/kg/day), haloperidol (3 but not 1 or 0.3 mg/kg/day), flupenthixol (3 but not 1 or 0.3 mg/kg/day), pimozide (4.5 but not 1.5 or 0.5 mg/kg/day) and loxapine (1.2 and 4 mg/kg/day but not 0.4 mg/kg/day). Sulphide (100 mg/kg/day), clozapine (30 mg/kg/ day) and haloperidol (3 mg/kg/day) all up-regulated the D3 receptor mRNA in nucleus accumbens and olfactory tubercles but not striatum. D1 and D2 receptor mRNA was up-regulated in whole brain by haloperidol and loxapine only, and in the case of haloperidol this was localized to striatum and prefrontal cortex. Haloperidol, clozapine and sulphide all down-regulated D1 mRNA in hippocampus and additionally haloperidol and sulpiride down-regulated it in the cerebellum. This work shows that all the drugs tested upregulated D3 receptor, but effects on D1 and D2 receptors were less general.  相似文献   

19.
It is shown that tricalcium phosphate obeys the Heckel equation only if a particle density of 1.92 g/cm3 (rather than the true density of 3.1 g/cm3) is used to determine the relative density of compacts. It is shown by comparing mercury intrusion porosimetry data with nitrogen adsorption data, that a large portion of the solid has pores of diameters of less than 60 Å. It would appear that this part of the pore space is not compressible in conventional pressure ranges, and that it should not be considered part of the Heckel pore space. It is shown by hysteresis loops that (in as much as simple interpretations are permissible) there is a substantial amount of ink-bottle pores, and that both neck and cavity volumes decrease in a logical fashion with increased applied pressure.  相似文献   

20.
目的对不同来源的湖南产莲子中黄曲霉毒素G_1、G_2、B_2、B_1进行高效液相色谱-光化学衍生法测定。方法采用高效液相色谱–光化学衍生法,采用岛津GL Inertsil ODS-3色谱柱(250 mm×4.6 mm,5μm),流动相为甲醇–乙腈–水(35∶13∶52),柱温35℃;光化学衍生器(254 nm)激发波长λ_(ex)=360 nm,发射波长λ_(ex)=450 nm。结果黄曲霉毒素G_1、G_2、B_2、B_1分别在6.7~33.3、11.4~56.8、10.3~51.5、4.1~20.3 pg线性关系良好;平均回收率分别为98.07%、97.72%、96.11%、99.52%,RSD值分别为1.69%、1.40%、2.72%、1.34%(n=6)。9批莲子样品中,有6批未检出黄曲霉毒素,来自于农贸市场农户自存的2批次检出黄曲霉毒素B_1,实验室塑料袋包装储存1年的1批检出黄曲霉毒素B_1、B_2,但质量分数均低于法定标准限量。结论不同来源湖南产莲子中黄曲霉毒素质量分数均低于《中国药典》2020年版规定限量。该法测定结果准确、重复性良好,可为完善莲子安全性控制和质量标准提升提供实验依据。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号